AFP can bind to AFPR-positive MDSCs, and some studies have shown that conjugating AFP to specific toxins can kill MDSCs, resulting in the release of NK cells and cytotoxic lymphocytes, thereby enhancing immune responses against cancer cells [100,101]. This evidence concerns the gene AFP and cancer.